139 related articles for article (PubMed ID: 37459555)
21. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Anti-Spike IgG Antibody and ACE2 Receptor Binding Inhibition Levels among Breakthrough Stage Veteran Patients.
Chensue SW; Siler AF; Kim PS; Dimcheff DE; Daghfal DJ; Prostko J; Frias E; Linder KA; Schildhouse RJ
Microbiol Spectr; 2022 Dec; 10(6):e0274722. PubMed ID: 36409132
[TBL] [Abstract][Full Text] [Related]
23. The rates and symptoms of natural and breakthrough infection pre- and post- Covid-19 non-mRNA vaccination at various peaks amongst Iranian healthcare workers.
Jamalidoust M; Eilami O; Ashkan Z; Ziyaeyan M; Aliabadi N; Habibi M
Virol J; 2023 Aug; 20(1):182. PubMed ID: 37596593
[TBL] [Abstract][Full Text] [Related]
24. Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.
Ruhl L; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer J; Falk CS
Front Immunol; 2023; 14():1120010. PubMed ID: 37033958
[TBL] [Abstract][Full Text] [Related]
25. Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.
Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P; Ciesek S; Widera M; Dolff S; Dittmer U; Witzke O; Meyer F; Lindemann M; Schönfeld A; Rohn H; Krawczyk A
Front Immunol; 2023; 14():1150667. PubMed ID: 37520539
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of SARS-CoV-2 vaccination in the nursing home setting.
Rivasi G; Bulgaresi M; Bandinelli C; Balzi D; Tarantini F; Tognelli S; Lorini C; Buscemi P; Baggiani L; Landini G; Ungar A; Bonaccorsi G; Mossello E; Benvenuti E
J Am Geriatr Soc; 2022 May; 70(5):1336-1341. PubMed ID: 35347706
[TBL] [Abstract][Full Text] [Related]
27. Quantitative Analysis of SARS-CoV-2 Antibody Levels in Cancer Patients Post Three Doses of Immunization and Prior to Breakthrough COVID-19 Infections.
Macrae K; Martinez-Cajas J; Bessai K; Abdulhamed A; Gong Y
Curr Oncol; 2022 Sep; 29(10):7059-7071. PubMed ID: 36290831
[TBL] [Abstract][Full Text] [Related]
28. Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK.
Wei J; Matthews PC; Stoesser N; Newton JN; Diamond I; Studley R; Taylor N; Bell JI; Farrar J; Kolenchery J; Marsden BD; Hoosdally S; Jones EY; Stuart DI; Crook DW; Peto TEA; Walker AS; Pouwels KB; Eyre DW;
Nat Commun; 2023 May; 14(1):2799. PubMed ID: 37193713
[TBL] [Abstract][Full Text] [Related]
29. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study.
Moscara L; Venerito V; Martinelli A; Di Lorenzo A; Toro F; Violante F; Tafuri S; Stefanizzi P
Vaccine; 2023 Aug; 41(38):5655-5661. PubMed ID: 37544827
[TBL] [Abstract][Full Text] [Related]
30. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Almendro-Vázquez P; Chivite-Lacaba M; Utrero-Rico A; González-Cuadrado C; Laguna-Goya R; Moreno-Batanero M; Sánchez-Paz L; Luczkowiak J; Labiod N; Folgueira MD; Delgado R; Paz-Artal E
Front Immunol; 2022; 13():981350. PubMed ID: 36059485
[TBL] [Abstract][Full Text] [Related]
31. Trends and Correlates of Breakthrough Infections With SARS-CoV-2.
Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M
Front Public Health; 2022; 10():856532. PubMed ID: 35619825
[TBL] [Abstract][Full Text] [Related]
32. Impact of SARS-CoV-2 vaccination in inflammatory bowel disease patients with different biological agents: a systematic review and meta-analysis.
Dai C; Dong ZY; Wang YN; Huang YH; Jiang M
Rev Esp Enferm Dig; 2023 Jun; 115(6):306-314. PubMed ID: 36353949
[TBL] [Abstract][Full Text] [Related]
33. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
34. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico.
Galán-Huerta KA; Flores-Treviño S; Salas-Treviño D; Bocanegra-Ibarias P; Rivas-Estilla AM; Pérez-Alba E; Lozano-Sepúlveda SA; Arellanos-Soto D; Camacho-Ortiz A
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062359
[TBL] [Abstract][Full Text] [Related]
36. Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination.
Finsterer J; Scorza FA
J Korean Med Sci; 2021 Oct; 36(40):e288. PubMed ID: 34664806
[No Abstract] [Full Text] [Related]
37. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
Mayo S; Monfort S
J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
[No Abstract] [Full Text] [Related]
38. Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.
Finsterer J
J Korean Med Sci; 2022 Jul; 37(26):e217. PubMed ID: 35790211
[No Abstract] [Full Text] [Related]
39. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
Taquet M; Dercon Q; Harrison PJ
Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
[TBL] [Abstract][Full Text] [Related]
40. Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19.
de Michelena P; Torres I; Albert E; Bracho A; González-Candelas F; Navarro D
J Infect; 2022 Apr; 84(4):579-613. PubMed ID: 35016898
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
